Reporter gene assays (RGA) are sensitive and versatile methods used extensively to study regulatory sequences, gene expression, signaling pathways and transcriptional activity, among other applications. Reporter gene assays are widely used by scientists in both, industry and academia. As life science suppliers continue improving products and services in the reporter gene assays market, reporter gene assay kits and reagents represent a significant market within the life sciences industry.
In order to explore the characteristics and dynamics of the market for reporter gene assays in depth, Percepta has launched the first in the series of Reporter Gene Assays Dashboard™ for the North American and European markets. This 2013 Dashboard provides a snapshot of the current reporter gene assays market landscape, to establish a foundation of data to which future series of Life Science Dashboards can be compared, giving Dashboard readers the ongoing story of how the market is adapting to new products, new competitors and sales and marketing strategies.
The 2013 Reporter Gene Assays Dashboard™ was developed from responses to a 27-question survey completed by 433 scientists located in North America and Europe. This Dashboard reveals key market indicators for the reporter gene assays market as a whole as well as for the following techniques representing market sub-segments:
- Beta-galactosidase (LacZ) assays
- Chloramphenicol acetyltransferase (CAT) assays
- Fluorescent protein related assays, e.g. GFP, YFP, etc.
- Luciferase assays
- Other reporter gene assays, e.g. beta-glucuronidase (GUS), secreted alkaline phosphatase (SEAP), human growth hormone (HGH) reporter assays, beta-lactamase, etc.
Note: Some of the reagents listed above are also used for applications such as determining cell viability and ADME-Tox testing. However, these are unrelated to reporter gene assays and are not included in market size and growth rate calculations in this report.
In June of 2013, Percepta fielded the Reporter Gene Assays Survey to a subset of the company’s panel of life scientists. Individuals were invited by e-mail blast to click through to a webpage at perceptabioanalytix.com where the survey was hosted. Invitations were delivered on June 5, 2013 and results collected through June 13, 2013. A total of 433 scientists completed the survey. Results are based on the aggregate of collected responses.
List of Companies Surveyed
Please note that respondents were provided with an option to list other suppliers.
- EMD Millipore
- GE Healthcare Life Sciences
- Gold Biotechnology
- Life Technologies/Invitrogen
- Perkin Elmer
- Roche Applied Sciences
- Sigma Aldrich
- Switchgear Genomics
- Thermo Fisher Scientific/Pierce
Table of Contents
5 Executive Summary
7 Dashboard “At A Glance”
10 Market Opportunity Matrix
12 Respondents Qualification
16 Frequency of Performance: Life Science Techniques
20 Frequency of Performance: Reporter Gene Assays
36 Co-Performance: Reporter Gene Assays & Life Science Techniques
38 Reagent Format Preference
42 Detection Technology Preference
44 Throughput, Growth Rates, Price & Monthly Spend
54 Market Size
56 Market Shares by Segment (Share of Mentions)
71 Customer Satisfaction & Interest in Switching
76 Purchase Decision Factors: Product Features
80 Research Focus & Target
86 Desired Product Changes
93 Appendix I: Supporting Data
105 Appendix II: Survey Methodology & Questionnaire
119 Appendix III: Life Science Dashboards™ Available
Available upon request